HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,006,684 | +4.7% | 52,531 | -1.2% | 1.11% | +13.1% |
Q2 2023 | $1,917,193 | -17.1% | 53,152 | -12.2% | 0.98% | -24.2% |
Q1 2023 | $2,311,908 | -0.8% | 60,537 | +47.8% | 1.29% | -10.7% |
Q4 2022 | $2,330,453 | +45.5% | 40,957 | +1.1% | 1.45% | +34.6% |
Q3 2022 | $1,602,000 | – | 40,508 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
2Xideas AG | 600,799 | $22,950,522 | 2.54% |
BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |